Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Beta Bionics (BBNX) Shares Outstanding (2023 - 2026)

Beta Bionics' Shares Outstanding history spans 4 years, with the latest figure at $44.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 2.79% to $44.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $44.6 million, a 2.79% increase, with the full-year FY2025 number at $44.4 million, up 565.3% from a year prior.
  • Shares Outstanding hit $44.6 million in Q1 2026 for Beta Bionics, roughly flat from $44.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding for BBNX hit a ceiling of $44.6 million in Q1 2026 and a floor of $6.0 million in Q4 2023.
  • Historically, Shares Outstanding has averaged $25.2 million across 4 years, with a median of $25.0 million in 2024.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 619.91% in 2025 and later rose 2.79% in 2026.
  • Tracing BBNX's Shares Outstanding over 4 years: stood at $6.0 million in 2023, then grew by 10.74% to $6.7 million in 2024, then soared by 565.3% to $44.4 million in 2025, then grew by 0.45% to $44.6 million in 2026.
  • Business Quant data shows Shares Outstanding for BBNX at $44.6 million in Q1 2026, $44.4 million in Q4 2025, and $44.0 million in Q3 2025.